Aspen Pharmacare Holdings LimitedJSE: APN

APN: APAC divestment boosts balance sheet strength, enabling growth and potential share buybacks

· Issued by Aspen Pharmacare Holdings Limited

Completion of the APAC divestment delivered ZAR 28 billion in proceeds, strengthening the balance sheet and enabling a near net cash position. Focus now shifts to organic growth, profitability restoration, and potential share buybacks, leveraging strong free cash flow and existing assets.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Aspen Pharmacare

All Aspen Pharmacare news releases